Formation Bio

📍 New York, United States🗓 Founded 2013👥 193 employees💰 Last funded Apr 2021
Biotechnology Research🌐 formation.bio
Website LinkedIn
Formation Bio is an AI-native pharma company differentiated by radically more efficient drug development. The company has built proprietary technology platforms to optimize critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. Formation Bio acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop assets faster, unlocking greater value per program and ultimately accelerate access to new treatments for patients. 2025 CNBC Disruptor 50 2025 Fierce 15 Award 2024 Endpoints 11 Award
5
Total investors
0
Early stage
2
Mid stage
3
Late stage
2013
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
5
Investor activity2018–2021 · investors recorded per year
2018220213
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Formation Bio?
Formation Bio has 5 investors on record on gritt.io, 2 mid-stage and 3 late-stage investors.
When did Formation Bio last raise funding?
The most recent investment in Formation Bio recorded on gritt.io was in April 2021.
When was Formation Bio founded?
Formation Bio was founded in 2013.
What industry is Formation Bio in?
Formation Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Formation Bio based?
Formation Bio is headquartered in New York, United States.